3 ms·
AI doesn't solve the underlying issue that made ketamine depression treatment expensive: intellectual property rights on a particular molecule. If a company ac
by k_sh 8y ago
AI doesn't solve the underlying issue that made ketamine depression treatment expensive: intellectual property rights on a particular molecule.
If a company achieved AI that can identify effective alternatives, why wouldn't they just acquire the patents for all of those alternatives and prop up all the prices?
- kkarakk 8y agoThere will be AIs to obscure other AIs work and AIs to clarify the obscured work. The rat race will never end